ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
HOUSTON---June 3, 2014---GE (NYSE: GE) today announced that it has successfully completed its acquisition of Cameron's Reciprocating Compression division for $550 million USD.
The division provides reciprocating compression equipment and aftermarket parts and services for oil and gas production, gas processing, gas distribution and independent power industries. Cameron's Reciprocating Compression division has approximately 900 employees and operates from 20 global locations.
Next-generation OligoProcess system has potential to help pharmaceutical industry save time and money
CHALFONT ST. GILES, UK and FRANKFURT, GERMANY -- 13 May 2014 -- GE Healthcare Life Sciences (NYSE: GE) and German oligonucleotide manufacturer BioSpring GmbH announced today that BioSpring has selected and installed GE Healthcare Life Sciences' OligoProcess, a fully automated oligonucleotide synthesizer, as a core element of its state-of-the-art production facility in Frankfurt.
GE today announced the appointment of its long-term CEO for Australia and NZ, Steve Sargent to the role of President and CEO of GE Mining, its global mining technology and services business. GE also announced the appointment of Geoff Culbert as President and CEO, GE Australia & New Zealand to succeed Mr Sargent.
Australian Mid-Market businesses are gearing up for managed growth. It's just one of the key findings of the 2014 GE Capital Australian Mid-Market Report launched today.
GE ecomagination today launched a global open innovation challenge to accelerate the development of innovative solutions focused on increased energy efficiency in seawater desalination. Four winners will be awarded a prize of $50,000 each and the possibility of further commercialisation for the best ideas.
Barrington, IL -- April 15, 2014 -- GE Healthcare announced today it has completed the acquisition of CHCA Computer Systems Inc., an operating room (OR) management and analytics solutions provider, headquartered in Montreal, Canada. CHCA develops the leading Opera software application, which has helped increase productivity and patient satisfaction in the OR by providing real-time data to support the decision making and management of surgical procedures.
GE (NYSE:GE) announced today that it has completed the acquisition of Thermo Fisher's HyClone™ cell culture media and sera, and gene modulation and magnetic beads businesses. The acquisition allows GE to expand its offering of tools, technologies and services for the discovery and manufacture of innovative new medicines, vaccines and diagnostics in its growing Life Sciences business.
Commenting on the acquisition, Brian Hood, General Manager of GE Healthcare's A&NZ Life Sciences business was excited about the latest addition to the Life Sciences portfolio.
GE Oil & Gas will showcase a range of its technology which supports the oil and gas sector when it exhibits at Australian Petroleum Production & Exploration Association (APPEA) Conference and Exhibition in Perth this week.
